文献速递消化道肿瘤与早癌

利用基于序列的粪便微生物群落调查数据识别结直肠癌复合生物标志物

Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
PubMed 文献 · Gut · 2017-03-24

该研究重新统一处理九项研究的原始16S rRNA基因序列数据,共分析509份样本(79例结直肠腺瘤、195例结直肠癌、235例对照),采用QIIME-CR和SS-UP两种流程,通过差异丰度、荟萃分析随机效应回归和机器学习评估微生物标志物。结果发现部分菌群在结直肠癌患者粪便中显著富集,微生物分类的AUROC在QIIME-CR为76.6%、SS-UP为80.3%,联合临床标志物后分别达83.3%和91.3%。作者认为关键微生物标志物可用于结直肠癌的通用诊断,但生物信息学流程的选择会影响分类准确性。

要点

  • 九项研究共509份样本(79例腺瘤、195例结直肠癌、235例对照)统一再分析。
  • CRC患者粪便中Parvimonas micra ATCC 33270、Streptococcus anginosus及未培养变形菌成员显著富集。
  • 微生物分类AUROC:QIIME-CR 76.6%,SS-UP 80.3%;联合临床标志物后分别为83.3%和91.3%。

核心结论

  • 尽管研究间存在技术和方 difference,关键微生物标志物在结直肠癌分类中显现重要性,可用于该病的通用诊断。
  • 生物信息学流程的选择影响分类准确性。
  • 菌株分辨的微生物标志物可能对提供结直肠癌的微生物诊断至关重要。

研究设计与样本

  • 重新统一分析九项研究的原始16S rRNA基因序列数据和元数据。
  • 数据分别用QIIME闭合参考(QIIME-CR)或称为SS-UP(Strain Select,UPARSE生物信息学流程)的菌株特异性方法处理。
  • 共分析509份样本,包括79例结直肠腺瘤、195例结直肠癌和235例对照。
  • 进行差异丰度、荟萃分析随机效应回归和机器学习分析,以确定潜在微生物标志物的一致性和诊断能力。

主要发现

  • 与对照相比,结直肠癌患者粪便中Parvimonas micra ATCC 33270、Streptococcus anginosus及未培养的变形菌成员等确定性分类群频繁且显著增加,在不同研究间一致,并在诊断分类中具有高区分能力。
  • 基于微生物组的结直肠癌与对照分类在QIIME-CR中产生的受试者工作特征曲线下面积(AUROC)为76.6%,在SS-UP中为80.3%。
  • 结合临床和微生物标志物后,QIIME-CR的诊断AUROC为83.3%,SS-UP为91.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality in the USA. The faecal microbiome may provide non-invasive biomarkers of CRC and indicate transition in the adenoma-carcinoma sequence. Re-analysing raw sequence and metadata from several studies uniformly, we sought to identify a composite and generalisable microbial marker for CRC. DESIGN: Raw 16S rRNA gene sequence data sets from nine studies were processed with two pipelines, (1) QIIME closed reference (QIIME-CR) or (2) a strain-specific method herein termed SS-UP (Strain Select, UPARSE bioinformatics pipeline). A total of 509 samples (79 colorectal adenoma, 195 CRC and 235 controls) were analysed. Differential abundance, meta-analysis random effects regression and machine learning analyses were carried out to determine the consistency and diagnostic capabilities of potential microbial biomarkers. RESULTS: Definitive taxa, including Parvimonas micra ATCC 33270, Streptococcus anginosus and yet-to-be-cultured members of Proteobacteria, were frequently and significantly increased in stools from patients with CRC compared with controls across studies and had high discriminatory capacity in diagnostic classification. Microbiome-based CRC versus control classification produced an area under receiver operator characteristic (AUROC) curve of 76.6% in QIIME-CR and 80.3% in SS-UP. Combining clinical and microbiome markers gave a diagnostic AUROC of 83.3% for QIIME-CR and 91.3% for SS-UP. CONCLUSIONS: Despite technological differences across studies and methods, key microbial markers emerged as important in classifying CRC cases and such could be used in a universal diagnostic for the disease. The choice of bioinformatics pipeline influenced accuracy of classification. Strain-resolved microbial markers might prove crucial in providing a microbial diagnostic for CRC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Shah MS, DeSantis TZ, Weinmaier T, et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut. 2017. PMID: 28341746. doi:10.1136/gutjnl-2016-313189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。